Cultured adult rat jejunal explants as a model for studying regulation of CYP3A
dc.contributor.author | Schmiedlin-Ren, Phyllissa | en_US |
dc.contributor.author | Benedict, Patrick E. | en_US |
dc.contributor.author | Dobbins, III, William O. | en_US |
dc.contributor.author | Ghosh, Mita | en_US |
dc.contributor.author | Kolars, Joseph C. | en_US |
dc.contributor.author | Watkins, Paul B. | en_US |
dc.date.accessioned | 2006-04-10T15:37:38Z | |
dc.date.available | 2006-04-10T15:37:38Z | |
dc.date.issued | 1993-09-01 | en_US |
dc.identifier.citation | Schmiedlin-Ren, Phyllissa, Benedict, Patricke E., Dobbins, III, William O., Ghosh, Mita, Kolars, Joseph C., Watkins, Paul B. (1993/09/01)."Cultured adult rat jejunal explants as a model for studying regulation of CYP3A." Biochemical Pharmacology 46(5): 905-918. <http://hdl.handle.net/2027.42/30618> | en_US |
dc.identifier.uri | http://www.sciencedirect.com/science/article/B6T4P-479DK5V-53/2/69922c65bd81e0b57caf2bfb42c0344c | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/30618 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=8373442&dopt=citation | en_US |
dc.description.abstract | Enzymes within the CYP3A subfamily are major Phase I drug-metabolizing enzymes present in hepatocytes and small bowel enterocytes. These enzymes are highly inducible in the liver by many structurally diverse compounds, including a number of commonly used medications. Studies indicate that CYP3A enzymes present in small bowel enterocytes are also inducible. However, the regulation of CYP3A enzymes in this tissue has not been well characterized, in part because in vivo studies are difficult, especially in humans. Our goal was to develop an in vitro model to study the regulation of CYP3A in enterocytes. To this end, we defined culture conditions under which adult rat jejunal explants maintained viable appearing villi for 21 hr. When dexamethasone, the prototypical inducer of CYP3A1 in rat hepatocytes, was added to the culture medium, there was a time-dependent induction of CYP3A1 mRNA and CYP3A protein in explant enterocytes which was essentially indistinguishable from the time course of induction of CYP3A1 mRNA and protein in enterocytes in vivo. This effect of dexamethasone appeared to be specific since dexamethasone had no consistent effect on the explant concentration of another enterocyte specific mRNA, intestinal fatty acid binding protein. Using this explant culture model, we found that CYP3A1 mRNA was also inducible by clotrimazole but we were unable to detect induction by rifampicin or troleandomycin. Our observations suggest that jejunal explants may provide an appropriate model for the study of the regulation of CYP3A and other drug-metabolizing enzymes. | en_US |
dc.format.extent | 1739428 bytes | |
dc.format.extent | 3118 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | Elsevier | en_US |
dc.title | Cultured adult rat jejunal explants as a model for studying regulation of CYP3A | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Biological Chemistry | en_US |
dc.subject.hlbtoplevel | Science | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Department of Internal Medicine, University of Michigan Medical Center and Veterans Administration Medical Center, Ann Arbor, MI 48109, U.S.A. | en_US |
dc.contributor.affiliationum | Department of Internal Medicine, University of Michigan Medical Center and Veterans Administration Medical Center, Ann Arbor, MI 48109, U.S.A. | en_US |
dc.contributor.affiliationum | no department Department of Internal Medicine, University of Michigan Medical Center and Veterans Administration Medical Center, Ann Arbor, MI 48109, U.S.A. found | en_US |
dc.contributor.affiliationum | Department of Internal Medicine, University of Michigan Medical Center and Veterans Administration Medical Center, Ann Arbor, MI 48109, U.S.A. | en_US |
dc.contributor.affiliationum | Department of Internal Medicine, University of Michigan Medical Center and Veterans Administration Medical Center, Ann Arbor, MI 48109, U.S.A. | en_US |
dc.contributor.affiliationum | Department of Internal Medicine, University of Michigan Medical Center and Veterans Administration Medical Center, Ann Arbor, MI 48109, U.S.A. | en_US |
dc.identifier.pmid | 8373442 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/30618/1/0000258.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1016/0006-2952(93)90501-M | en_US |
dc.identifier.source | Biochemical Pharmacology | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.